Sangsangin Co., Ltd. (KOSDAQ:038540)

Elevation Oncology Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 7, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	110,543	80,499	205,216	335,460	454,209	351,330
Market Cap Growth	-55.18%	-60.77%	-38.82%	-26.14%	29.28%	-26.01%
Enterprise Value	119,760	-124,384	498,183	319,229	525,508	322,770
Last Close Price	2020.00	1471.00	3750.00	6002.82	8038.09	6143.13
PE Ratio	-	-	-	7.08	4.49	5.66
PS Ratio	0.13	0.09	0.22	0.44	0.80	0.77
PB Ratio	0.19	0.14	0.26	0.40	0.57	0.51
P/TBV Ratio	0.26	0.19	0.33	0.48	0.71	0.66
P/FCF Ratio	0.35	0.12	-	7.16	1.68	-
P/OCF Ratio	0.35	0.12	-	5.36	1.63	-
EV/Sales Ratio	0.15	-	0.53	0.42	0.92	0.71
EV/EBITDA Ratio	-	-	-	4.26	3.75	3.14
EV/EBIT Ratio	-	-	-	4.99	3.99	3.40
EV/FCF Ratio	0.38	-	-	6.81	1.94	-
Debt / Equity Ratio	1.28	1.69	2.32	0.38	0.33	0.34
Debt / EBITDA Ratio	-	-	-	4.28	1.91	2.27
Debt / FCF Ratio	2.31	1.40	-	6.84	0.99	-
Asset Turnover	0.14	0.15	0.14	0.13	0.12	0.13
Inventory Turnover	165.99	175.08	86.14	47.12	32.86	37.34
Quick Ratio	1.15	1.07	0.97	7.01	7.30	6.41
Current Ratio	1.17	1.09	0.98	7.16	7.36	6.50
Return on Equity (ROE)	-32.94%	-31.44%	-7.55%	5.12%	13.70%	9.82%
Return on Assets (ROA)	-1.59%	-2.27%	-0.63%	0.66%	1.76%	1.64%
Return on Capital (ROIC)	-5.30%	-6.42%	-2.14%	3.57%	8.26%	6.49%
Return on Capital Employed (ROCE)	-	-	-	1.10%	2.50%	2.90%
Earnings Yield	-191.32%	-240.53%	-31.31%	14.12%	22.27%	17.66%
FCF Yield	284.56%	850.86%	-780.24%	13.97%	59.71%	-72.44%
Dividend Yield	-	-	-	1.67%	1.24%	-
Payout Ratio	-	-	-	23.11%	0.01%	17.64%
Buyback Yield / Dilution	-	-	-	-	-	0.99%
Total Shareholder Return	-	-	-	1.67%	1.24%	0.99%

Updated Mar 18, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.